David Brierley

Team Leader
Nina E. Weisser
David carried out a BSc at The University of Nottingham, followed by a PhD in Neurology at Kings College London. After two postdocs focused on phenotypic drug discovery in immunology/oncology at UCLA and CRUK respectively, he joined GSK in 2014 as a senior cell biologist. More recently, David leads a team of 7 bioscientists supporting assay development, compound profiling and mechanism of action studies predominantly during the target to candidate phase of drug discovery. A particular focus is to combine human disease relevant assays with emerging enabling technologies, to deliver medium to high throughput primary cell-based phenotypic assays that better link clinical efficacy to cellular compound screening.


No data was found